Author

P. Ormanoglu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:electrophysiology· 1

Frequent Co-Authors

A. Simeonov· 2 shared C. A. Tristan· 2 shared C. Malley· 2 shared I. Singec· 2 shared J. Slamecka· 2 shared P.-H. Chu· 2 shared S. Michael· 2 shared C. A. LeClair· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. Simeonov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Robotic High-Throughput Biomanufacturing and Functional Differentiation of Human Pluripotent Stem Cells

C. A. Tristan, P. Ormanoglu, J. Slamecka, C. Malley, P.-H. Chu, V. M. Jovanovic, Y. Gedik, C. Bonney, E. Barnaeva, J. Braisted, S. K. Mallanna, D. Dorjsuren, M. J. Iannotti, T. C. Voss, S. Michael, , I. Singec

This paper develops a robotic platform for high-throughput manufacturing and differentiation of human pluripotent stem cells, validated through molecular and functional analyses.

bioRxiv · Aug 3, 2020Bioengineering

A Versatile Polypharmacology Platform Promotes Cytoprotection and Viability of Human Pluripotent and Differentiated Cells

Y. Chen, C. A. Tristan, L. Chen, V. Jovanovic, C. Malley, P.-H. Chu, S. Ryu, T. Deng, P. Ormanoglu, D. Tao, Y. Fang, J. Slamecka, C. A. LeClair, S. Michael, C. P. Austin, , I. Singec

The paper identifies a small molecule cocktail, CEPT, that enhances the viability and cytoprotection of human pluripotent and differentiated cells through multi-target drug combinations.

bioRxiv · Oct 22, 2019Cell Biology